
Stock·NASDAQ·Financial Services
Northern Trust Corporation (NTRS)
- Market cap
- $32.37B
- P/E
- 14.02
- Dividend yield
- 1.84%
- Street target
- $182.00median of 16 analysts
- 52-week range
- $121.53 $195.78
NTRS stock today, November 12, 2026: price, news and analyst targets
As of November 11, 2026, Northern Trust Corporation (NTRS) trades at $178.71. Wall Street's median 12-month price target is $182.00 across 16 analysts, 1.8% above the price. CleaRank rates it Buy with a score of 73/100.
Northern Trust closed at $178.71 on November 11, 2026, up 0.46% on the session and 77% of the way up its 52-week range. The stock sits 8.72% below its 52-week high of $195.78 and 2.83% above its 50-day average, a set-up that has kept the trend positive even as analysts remain mostly on the sidelines. The main question for investors is whether the earnings beat streak and the price trend can carry the stock while the analyst consensus stays at Hold.
Earnings have beaten more often than not
Northern Trust has beaten the EPS estimate in seven of the last eight reports. The October 21, 2026 report was the largest beat of the last four reports: $3.40 against an estimate of $2.84, a 19.72% beat, followed by a 0.89% gain in the first session. The July 22, 2026 report was the one miss, with $4.23 against $4.62, and the stock fell 3.46% the next session. The pattern shows that investors are looking past the headline EPS figure to other details.
Revenue and profitability are holding up
The net profit margin is 25.4% and the operating margin is 34.80%, and return on equity is 18.44%, above the sector median of 13.8%. These figures support CleaRank's view that the business is profitable and carries a healthy balance sheet, and the company earns a health score of 4 out of 5.
Valuation is close to the sector
The trailing P/E ratio of 14.02, which is 15.0% below the sector median of 16.5, a comparison CleaRank describes as broadly in line with peers. The trailing dividend yield is 1.84%, based on an annual dividend of $3.28 per share. The stock is not priced at a steep discount, so the case for it rests on continued earnings growth rather than a large gap to peers.
Analysts remain cautious
Of 16 analysts, two rate the stock buy or strong buy, 12 rate it hold and two rate it sell or strong sell. Three months ago, two of 15 ratings were buy. Recent actions were mostly reiterations: JP Morgan kept its Neutral rating on October 30, 2026, Citigroup kept its Neutral rating on October 23, 2026, and Morgan Stanley kept its Underweight rating on October 22, 2026. TD Cowen restarted coverage at Hold on October 8, 2026, and BMO Capital kept its Outperform rating on October 6, 2026.
CleaRank score 73/100 (Buy). 16 of 19 checks pass: trend 4 of 4, momentum 3 of 3, valuation and quality 5 of 5, analysts 1 of 3, track record 3 of 4.
About Northern Trust
Northern Trust Corporation is a financial services company that provides wealth management, asset servicing, asset management, and banking solutions to corporations, institutions, families, and individuals. Northern Trust Corporation serves a diverse client base that includes retirement funds, foundations, endowments, fund managers, insurance companies, and affluent households, with offerings spanning custody, fund administration, investment operations outsourcing, securities lending, foreign exchange, treasury management, brokerage, and cash management.
NTRS stock news
Earnings beat in October
·Earnings report
The October 21, 2026 report showed EPS of $3.40 against a $2.84 estimate, a 19.72% beat, and the stock rose 0.89% in the next session. A beat of that size supports the case that earnings are running ahead of expectations.
JP Morgan keeps Neutral
·JP Morgan
JP Morgan kept its Neutral rating on October 30, 2026. The reiteration keeps the consensus at Hold and suggests the stock is not seen as a clear upgrade candidate.
Citigroup keeps Neutral
·Citigroup
Citigroup kept its Neutral rating on October 23, 2026. Another firm holding a middle view adds to the picture of a divided but cautious analyst base.
Morgan Stanley stays Underweight
·Morgan Stanley
Morgan Stanley kept its Underweight rating on October 22, 2026, a negative stance that signals doubt about the stock's near-term upside relative to the market.
BMO Capital stays Outperform
·BMO Capital
BMO Capital kept its Outperform rating on October 6, 2026, one of only two buy-side ratings among the 16 analysts covering the stock, which supports the positive minority view.
NTRS price target 2026
The base case is that the stock holds above its moving averages while earnings and revenue keep growing. Analysts expect earnings per share to rise 53.5% this fiscal year to $13.41, and revenue to grow 14.5% to $9.3B, so the trend has fundamental support. Analysts expect earnings to shrink 3.2% next year to $12.99, so the growth story depends on this year's numbers holding up. The median 12-month analyst target is $182.00, just 1.8% above the price, with a range from $158.00 to $194.00. A move toward the 52-week high of $195.78 would need stronger results and more analysts upgrading from Hold. A break below the 50-day average would weaken the trend and could bring the 200-day average into position.
Analyst targets and ratings
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 30, 2026 | JP Morgan | Maintains | Neutral |
| Oct 23, 2026 | Citigroup | Maintains | Neutral |
| Oct 22, 2026 | Morgan Stanley | Maintains | Underweight |
| Oct 22, 2026 | Barclays | Maintains | Equal-Weight |
| Oct 8, 2026 | TD Cowen | Reinstates | Hold |
| Oct 6, 2026 | BMO Capital | Maintains | Outperform |
NTRS support and resistance levels
Support sits at $173.79, the 50-day simple moving average, the nearest level below the price, and a close under it would be the first sign the short-term trend is weakening. Next is the 20-day exponential average at $172.85, which tracks recent prices more closely and sits just under the 50-day line. The 200-day simple moving average at $166.55 is the longer-term trend line, and the 52-week low of $121.53 marks the bottom of the past year's range. Resistance begins at the 52-week high of $195.78, the nearest level above the price and the level a rise would meet first.
| Level | What it is | Price | From the price |
|---|---|---|---|
| Resistance 1 | 52-week high | $195.78 | +9.6% |
| Price | November 11, 2026 | $178.71 | |
| Support 1 | 50-day moving average | $173.79 | -2.8% |
| Support 2 | 20-day exponential average | $172.85 | -3.3% |
| Support 3 | 200-day moving average | $166.55 | -6.8% |
| Support 4 | 52-week low | $121.53 | -32.0% |
Technical indicators
NTRS stock price and trading
NTRS share price
NTRS fundamentals and valuation
Key statistics
NTRS against the Financial Services sector
Price to earnings vs sector: Valuation is broadly in line with sector peers (-15% against the sector median P/E).
Return vs XLF: Since Jun 2, 2025, NTRS has gained 68.1% against a gain of 15.0% for XLF.
Performance against XLF
Revenue and earnings
Revenue growth: Revenue fell 2.5% in FY2025 to $8.1B, from $8.3B a year earlier.
Profit margin: The net margin was 21.5% in FY2025, down from 24.5% the year before.
Profitable: NTRS earned $1.7B in FY2025.
Earnings reality check
Earnings record: NTRS beat the analyst estimate in 7 of the last 8 quarters.
Market reaction: The stock fell in the first session after 2 of those 7 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Oct 21, 2026before open | $2.84 | $3.40 | +19.72% | +0.89% | +2.97% |
| Jul 22, 2026before open | $4.62 | $4.23 | -8.44% | -3.46% | -2.27% |
| Apr 21, 2026before open | $2.33 | $2.71 | +16.31% | +8.02% | +5.55% |
| Jan 22, 2026before open | $2.35 | $2.42 | +2.98% | +6.02% | +4.04% |
| Oct 22, 2025before open | $2.25 | $2.29 | +1.78% | -2.37% | -0.92% |
| Jul 23, 2025before open | $2.06 | $2.13 | +3.40% | -1.82% | +4.04% |
| Apr 22, 2025before open | $1.84 | $1.90 | +3.26% | +2.97% | +6.60% |
| Jan 23, 2025before open | $2.03 | $2.26 | +11.33% | +2.00% | +4.85% |
NTRS price history and drawdowns
Risk profile
Worst falls and recoveries
Growth of $10,000
Against the market: NTRS trailed the S&P 500 over this period: $27,246 against $40,494.
A $10,000 investment in NTRS in December 2016 would be worth about $27,246 today with dividends reinvested, compared with about $40,494 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
NTRS stock price prediction 2030
NTRS Stock Price Prediction 2030: Simulated Scenarios
CleaRank's simulation projects a price near $234 for NTRS by 2030 in the base case, from $179 today (1.3x over 4 years). The 10th-percentile path ends near $108. These are outcomes of a Monte Carlo simulation run on NTRS's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $130 | $191 | $282 | |
| 2028 | $118 | $205 | $355 | |
| 2029 | $112 | $219 | $430 | |
| 2030 | $108 | $234 | $510 |
NTRS insider trading
NTRS insider trading
Month by month
Net insider selling: Insiders bought $876K on the open market and sold $22.2M.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Oct 30, 2026 | Robert Edward Moritz Jr.
Director
|
Buy | 236 | $39.9K |
| Oct 26, 2026 | Susan Cohen Levy
General Counsel
|
Sell | 20.9K | $3.5M |
| Oct 26, 2026 | Susan Cohen Levy
General Counsel
|
Option | 20.9K | $1.8M |
| Oct 20, 2026 | Rima Qureshi
Director
|
Grant | 495 | - |
| Aug 24, 2026 | Thomas A South
Officer
|
Sell | 1.8K | $332.8K |
| Jul 29, 2026 | Robert Edward Moritz Jr.
Director
|
Buy | 255 | $45.8K |
| Jul 1, 2026 | Chandra Dhandapani
Director
|
Grant | 227 | $39.6K |
| Jul 1, 2026 | Dean M Harrison
Director
|
Grant | 389 | $68.0K |
| Jul 1, 2026 | Marcy S Klevorn
Director
|
Grant | 57 | $10.0K |
| Jul 1, 2026 | Siddharth N Mehta
Director
|
Grant | 26 | $4.7K |
NTRS stock forecast: questions people ask
NTRS Forecast: Frequently Asked Questions
What is the NTRS stock forecast?
What is the NTRS price target?
Is NTRS a buy or sell today?
How has NTRS performed over the past year?
How much has Northern Trust grown its earnings and revenue?
Are insiders buying or selling NTRS?
How does the NTRS dividend compare?
How these figures are computed, and where the data comes from: CleaRank methodology.